Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chitose Laboratory is a Japan-based biotechnology company within the CHITOSE Group that focuses on research, development, and commercialization support across industrial biotech and healthcare-related applications. In healthcare, the company has built a biopharmaceutical manufacturing platform centered on its proprietary CHO-MK host cell line and CS CHO expression vector system for high-yield stable cell line development. It also develops mammalian cell technologies for antibody production and gene therapy manufacturing support. Beyond healthcare, the company applies microorganism, cell line, and microalgae cultivation technologies to broader bioeconomy initiatives spanning food, agriculture, chemicals, and resource circulation. Chitose Laboratory appears to operate primarily as a platform and technology services company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chitose Laboratory.